Helicobacter pylori and extradigestive disorders in the past 10 years

Iranian Red Crescent Medical Journal

Volumn 11, Issue 2, 2009, Pages 123-132

  Farshad, Shohreh ^a   Japoni, A ^a   Alborzi, A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Extradigestive disorders; Helicobacter pylori

Indexed keywords

BACTERIAL DNA; CAGA PROTEIN; VACUOLATING TOXIN;

ANTIBODY TITER; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BLEPHARITIS; DISEASE ASSOCIATION; EYE DISEASE; GENETIC SUSCEPTIBILITY; HEART DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATOBILIARY DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; NONHUMAN; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCLERODERMA; SEROLOGY; SKIN DISEASE; UREA BREATH TEST;

EID: 67649415143     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995;333:984-991. [7666920] [doi: 10.1056/NEJM199510123331508]
2. Olson JW, Maier RJ. Molecular hydrogen as an energy source for Helicobacter pylori. Science 2002;298:1788-1790. [12459589] [doi:10.1126/science. 1077123]
3. Stark RM, Gerwig GJ, Pitman RS, Potts LF, Williams NA, Greenman J, Weinzweig IP, Hirst TR, Millar MR. Biofilm formation by Helicobacter pylori. Lett Appl Microbiol 1999;28: 121-126. [10063642] [doi:10.1046/j.1365-2672.1999.00481.x]
4. Chan WY, Hui PK, Leung KM, Chow J, Kwok F, Ng CS. Coccoid forms of Helicobacter pylori in the human stomach. Am J Clin Pathol 1994; 102:503-7. [7524304]
5. Liu ZF, Chen CY, Tang W, Zhang JY, Gong YQ, Jia JH. Gene-expression profiles in gastric epithelial cells stimulated with spiral and coccoid Helicobacter pylori. J Med Microbiol 2006;55:1009-15. [16849720] [doi:10.1099/jmm.0.46456-0]
6. Marshall BJ. Helicobacter Foundation. 2006; http://www.helico.com
7. Megraud F. Toxic factors of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:S5-10. [7735936]
8. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988;26:93-9. [3385767]
9. Chen XG, Correa P, Offerhaus J, Rodriguez E, Janney F, Hoffmann E, Fox J, Hunter F, Diavolitsis S. Ultra-structure of gastric mucosa harbouring Campylobacter like organisms. Am J Clin Path 1986; 86:575-82. [2430450]
10. Gasbarrini A, Franceschi F, Armuzzi A, Ojetti V, Candelli M, Sanz Torre E, De Lorenzo A, Anti M, Pretolani S, Gasbarrini G. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 1999;45:I9-I12. [10457029]
11. Crabtree JE. Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol Suppl 1996; 215:3-10. [8722376] [doi:10.3109/00365529609094526]
12. Negrini R, Savio A, Poiesi C, Appelmelk BJ, Buffoli F, Paterlini A, Cesari P, Graffeo M, Vaira D, Franzin G. Antigenic mimicry between H. pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996;111:655-65. [8780570] [doi:10.1053/gast.1996.v111.pm8780570]
13. Langman MJ, Cooke AR. Gastric and duodenal ulcer and their associated diseases. Lancet 1976;1:680-3. [73651] [doi:10.1016/ S0140-6736(76)92790-2]
14. Asensio-Sánchez VM, Rodríguez-Delgado B, García-Herrero E, Cabo-Vaquera V, García-Loygorri C. Central Serous Chorioretinopathy As An Extradigestive Manifestation Of Helicobacter Pylori Gastric Infection. Arch Soc Esp Oftalmol 2008;83:177-82. [18311677]
15. Sacca SC, Pascotto A, Venturino GM, Prigione G, Mastromarino A, Baldi F, Bilardi C, Savarino V, Brusati C, Rebora A. Prevalence and Treatment of Helicobacter pylori in Patients with Blepharitis. Invest Ophthalmol Vis Sci 2006;47:501-8. [16431942] [doi:10.1167/ iovs.05-0323]
16. Manolakis A, Kapsoritakis AN, Potamianos SP. A Review of the Postulated Mechanisms Concerning the Association of Helicobacter pylori with Ischemic Heart Disease. Helicobacter 2007;12:287-97. [17669100] [doi:10. 1111/j.1523-5378.2007.00511.x]
17. Farshad S, Alborzi A, Malekhosseini SA, Gramizadeh B, Oboodi B, Rasouli M, Japoni A, Kalani M, Pourabbas B. Detection of Helicobacter DNA in Bile Samples of Patients with Biliary Diseases Living in South of Iran. IJMS 2006;31:186-90.
18. Solnick JV, Schauer DB. Emergence of Diverse Helicobacter Species in the Pathogenesis of Gastric and Entero-hepatic Disease. Clin Microbiol Rev 2001;14:59-97. [11148003] [doi:10.1128 /CMR.14.1.59-97.2001]
19. Lin TT, Yeh CT, Wu CS, Liaw YF. Detection and partial sequence analysis of Helicobacter pylori DNA in the bile samples. Dig Dis Sci 1995;40:2214-9. [7587792] [doi:10.1007/BF02209009]
20. Figura N, Cetta F, Angelico M, Montalto G, Cetta D, Pacenti L, Vindigni C, Vaira D, Festuccia F, De Santis A, Rattan G, Giannace R, Campagna S, Gennari C. Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile. Is it a risk factor for gallstone formation? Dig Dis Sci 1998;43:854-62. [9558044] [doi:10.1023/ A:1018838719590]
21. Myung SJ, Kin MH, Shim KN, Kim YS, Kim EO, Kim HJ, Park ET, Yoo KS, Lim BC, Seo DW, Lee SK, Min YI, Kim JY. Detection of Helicobacter pylori DNA in human biliary tree and its association with Hepatolithiasis. Dig Dis Sci 2000;45:1405-12. [10961722] [doi:10.1023/ A:1005572507572]
22. Nilsson HO, Mulchandani R, Tranbery KG, Stenram U, Wadström T. Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 2001;120:323-4. [11246512] [doi:10.1053/gast.2001.21382]
23. Fallone CA, Tran S, Semert M, Discepola F, Behr M, Barkun AN. Helicobacter DNA in bile: correlation with hepato-biliary disease. Aliment Pharmacol Ther 2003;17:453-8. [12562460] [doi:10.1046/ j.1365-2036.2003.01424.x]
24. Monstein HJ, Jonsson Y, Zdolsek J, Svanvik J. Identification of Helicobacter pylori in human cholesterol gallstones. Scand J Gastroenterol 2002; 37:112-9. [11843027] [doi:10.1080/ 003655202753387455]
25. Wadstrom T, Ljungh A, Willen R. Primary biliary cirrhosis and primary sclerosing cholangitis are of infectious origin! Gut 2001; 49:454. [11550663]
26. Farshad S, Alborzi A, Malek Hosseini SA, Oboodi B, Rasouli M, Japoni A, Nasiri J. Identification of Helicobacter pylori DNA in Iranian patients with gallstones. Epidemiol infec 2004; 132:1185-9.
27. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ, Gorelick PL, Nagashima K, Gonda MA, Gilden RV. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 1994;86:1222-7. [8040890] [doi:10.1093/jnci/86.16.1222]
28. Taylor NS, Fox JG, Yan L. In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species. J Med Microbiol 1995; 42:48-52. [7739025]
29. Ponzetto A, Pellicano R, Leone N, Cutufia MA, Turrini F, Grigioni WF, D'Errico A, Mortimer P, Rizzetto M, Silengo L. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses 2000;54:275-7. [10790764] [doi:10.1054/mehy.1999.0987]
30. Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac Sage P, Balabaud C, Megraud F. Detection of Helicobacter species in the liver of patients with and without primary liver cancer. Cancer 2000; 89:1431-9. [11013355] [doi:10.1002/ 1097-0142(20001001)89:7<1431::AID-CNCR4>3.0.CO;2-5]
31. Giannini E, Fasoli A, Botta F, Romagnoli P, Malfatti F, Chiarbonello B, Mamone M, Savarino V, Testa R. Helicobacter Pylori Infection is Associated With Greater Impairment Of Cytochrome P-450 Liver Metabolic Activity In Anti-Hcv Positive Cirrhotic Patients. Dig Dis Sci 2003;48:802-8. [12741475] [doi:10.1023/A:1022861414826]
32. Mindel JS, Rosenberg EW. Is Helicobacter pylori of interest to ophthalmologists? Ophthalmology 1997;104:1729-30. [9373098]
33. Franceschi F, Gasbarrini A, Fontana L. Role of Helicobacter pylori infection in ophthalmology. Ophthalmology 1998;105:1351-2. [9709737] [doi:10.1016/S0161-6420(98)98004-6]
34. Sacca SC, Pascotto A, Venturino GM, Prigione G, Mastromarino A, Baldi F, Bilardi C, Savarino V, Brusati C, Rebora A. Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci 2006;47:501-8. [16431942] [doi:10.1167/ iovs.05-0323]
35. Mauget-Faysse M, Kodjikian L, Quaranta M, Ben Ezra D, Trepsat C, Mion F, Mégraud F. Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study. J Fr Ophtalmol 2002; 25:1021-5. [12527825]
36. Ahnoux-Zabsonre A, Quaranta M, Mauget-Faysse M. Prevalence of Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy: a complementary study. J Fr Ophtalmol 2004;27: 1129-33. [15687922] [doi:10.1016 /S0181-5512(04)96281-X]
37. Giusti C. Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis. Med Hypotheses 2004;63:524-7. [15288381] [doi:10.1016 /j.mehy.2004.02.020]
38. Giusti C, Mauget-Faysse M. Helicobacter pylori and idiopathic central serous chorioretinopathy. Swiss Med Wkly 2004; 134:395-8. [15389356]
39. de Martel C, Parsonnet J. Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci 2006;51:2292-301. [17089189] [doi:10.1007/ s10620-006-9210-5]
40. Logan RP, Walker MM. ABC of the upper gastrointestinal tract: Epidemiology and diagnosis of Helicobacter pylori infection. BMJ 2001;323:920-2. [11668141] [doi:10.1136 /bmj.323.7318.920]
41. Logan RP, Berg DE. Genetic diversity of Helicobacter pylori. Lancet 1996;348:1462-3. [8942769] [doi:10.1016 /S0140-6736(05)65885-0]
42. Mc Culley JP, Doughertly J, Deneau DG. Classification of chronic blepharitis. Ophthalmology 1982;89: 1173-80. [6218459]
43. McCulley JP, Shine WE. Eyelid disorders: the meibomian gland, blepharitis, and contact lenses. Eye Contact Lens 2003; 29:S93-5. [12772741] [doi:10.1097/00140068-200301001-00026]
44. Rebora A. The management of rosacea. Am J Clin Dermatol 2002; 3:489-96. [12180896] [doi:10.2165/00128071-200203070-00005]
45. Kountouras J, Mylopoulos N, Boura P, Bessas C, Chatzopoulos D, Venizelos J, Zavos C. Relationship between Helicobacter pylori infection and glaucoma. Ophthalmology 2001; 108:599-604. [11237916] [doi:10.1016/S0161-6420(00)00598-4]
46. Galloway PH, Warner SJ, Morshed MG, Mikelberg FS. Helicobacter pylori infection and the risk for openangle glaucoma. Ophthalmology 2003;110:922-5. [12750090] [doi:10.1016 /S0161-6420(03)00093-9]
47. Giusti C. Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis. Med Hypotheses 2004; 63:524-7. [15288381] [doi:10.1016 /j.mehy.2004.02.020]
48. Ahnoux-Zabsonre A, Quaranta M, Mauget-Faysse M. Prevalence of Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy: a complementary study. J Fr Ophtalmol 2004;27: 1129-33. [15687922] [doi:10.1016 /S0181-5512(04)96281-X]
49. Chen TS, Chang FY, Chen PC, Huang TW, Ou JT, Tsai MH, Wu MS, Lin JT. Simplified 13C-UBT with a new infrared spectrometer for diagnosis of Helicobacter pylori infection. J Gastroenterol Hepatol 2003; 18:1237-43. [14535979] [doi:10.1046 /j.1440-1746.2003.03139.x]
50. Bilardi C, Biagini R, Dulbecco P, Iiritano E, Gambaro C, Mele MR, Borro P, Tessieri L, Zentilin P, Mansi C, Vigneri S, Savarino V. Stool antigen assay (H. pylori SA) is less reliable than UBT for post-treatment diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16:1733-8. [12269965] [doi:10.1046/ j.1365-2036.2002.01345.x]
51. Kendall SN. Remission of rosacea induced by reduction of gut transit time. Clin Exp Dermatol 2004; 29:297-9. [15115515] [doi:10.1111/j.1365-2230.2004.01461.x]
52. Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea 2003; 22:230-3. [12658088] [doi:10.1097/ 00003226-200304000-00009]
53. Boni R. Rosacea, acne and other diseases of the seborrheic spectrum. Schweiz Rundsch Med Prax 2000;89:566-70. [10815463]
54. Diaz C, O'Callaghan CJ, Khan A, Ilchyshyn A. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study. Acta Derm Venereol 2003;83:282-6. [12926800] [doi:10.1080/ 00015550310016544]
55. Charlett A, Dobbs RJ, Dobbs SM, Weller C, Brady P, Peterson DW. Parkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome. Acta Neurol Scand 1999;99:26-35. [9925235]
56. Gupta AK, Bluhm R, Cooper EA, Summerbell RC, Batra R. Seborrheic dermatitis. Dermatol Clin 2003; 21:401-12. [12956195] [doi:10.1016/S0733-8635(03)00028-7]
57. Michel JL, Cabibel F. Frequency, severity and treatment of ocular rosacea during cutaneous rosacea. Ann Dermatol Venereol 2003; 130: 20-4. [12605152]
58. Kountouras J, Zavos C, Chatzopoulos D. Induction of apoptosis as a proposed pathophysiological link between glaucoma and Helicobacter pylori infection. Med Hypotheses 2004;62: 378-81. [14975507] [doi:10.1016/j.mehy.2003.11.013]
59. Kountouras J, Deretzi G, Zavos C, Karatzoglou P, Touloumis L, Nicolaides T, Chatzopoulos D, Venizelos I. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2005;12:139-43. [15679702] [doi:10.1111/j.1468-1331.2004.00977.x]
60. Kountouras J, Zavos C, Chatzopoulos D. Primary open-angle glaucoma: pathophysiology and treatment. Lancet 2004;364:1311-2. [15474127] [doi:10.1016/S0140-6736(04)17179-1]
61. Mendall M, Goggin M, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and corona ry heart disease. Br Heart J 1994;71:437-9. [8011406] [doi:10.1136/hrt.71.5.437]
62. Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesäniemi YA, Syrjälä SL, Jungell PS, Isoluoma M, Hietaniemi K, Jokinen MJ. Association between dental health and acute myocardial infarction. BMJ 1989;298:779-81. [2496855]
63. Gupta S, Leatham E, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivor of myocardial infarction. Circulation 1997;96:404-7. [9244203]
64. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997;350:404-7. [9259655] [doi:10.1016/S0140-6736(97)07201-2]
65. Maier F, Auricchio A, Nilius M, Dominguez-Munoz JE, Klein H. Lack of association between Helicobacter pylori infection and angiographically documented Coronary Heart Disease. Gut 1996; 39:A92.
66. Delaney BC, Hobbs FDR, Holder R. Association of Helicobacter pylori infection with coronary heart disease. Eradication of the infection on grounds of cardiovascular risk is not supported by current evidence. BMJ 1996;312:251-2. [8563611]
67. Elkind MS, Cole JW. Do common infections cause stroke? Semin Neurol 2006;26:88-99. [16479447] [doi:10.1055/s-2006-933312]
68. Al-Nozha MM, Khalil MZ, Al-Mofleh IA, Al-Ghamdi AS. Lack of association of coronary artery disease with H. pylori infection. Saudi Med J 2003;24:1370-3. [14710286]
69. Kanbay M, Gur G, Yucel M, Yilmaz U, Muderrisoglu H. Helicobacter pylori seroprovalence in patients with coronary artery disease. Dig Dis Sci 2005;50:2071-4. [16240217] [doi:10.1007/ s10620-005-3009-7]
70. Tsai CJ, Huang TY. Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease. Dig Dis Sci 2000;45:1227-32. [10877241] [doi:10.1023/A:1005522624004]
71. Stöllberger C, Mölzer G, Finsterer J. Seroprevalence of antibodies to microorganisms known to cause arterial and myocardial damage in patients with or without coronary stenosis. Clin Diagn Lab Immunol 2001;8:997-1002. [11527817] [doi:10.1128 /CDLI.8.5.997-1002.2001]
72. Zhu J, Quyyumi AA, Muhlestein JB, Nieto FJ, Horne BD, Zalles-Ganley A, Anderson JL, Epstein SE. Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death. Am J Cardiol 2002;89:155-8. [11792334] [doi:10.1016/S0002-9149(01)02192-0]
73. Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P, Tenkanen L, Manninen V, Hovi T, Manttari M. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000; 101:252-7. [10645920]
74. Ridker PM, Danesh J, Youngman L, Collins R, Stampfer MJ, Peto R, Hennekens CH. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann Intern Med 2001; 135:184-8. [11487485]
75. Haider AW, Wilson PW, Larson MG, Evans JC, Michelson EL, Wolf PA, O'Donnell CJ, Levy D. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol 2002;40:1408-13. [12392829] [doi:10.1016/ S0735-1097(02)02272-6]
76. Coles KA, Knuiman MW, Plant AJ, Riley TV, Smith DW, Divitini ML. A prospective study of infection and cardiovascular diseases: the Busselton Health Study. Eur J Cardiovasc Prev Rehabil 2003; 10:278-82. [14555883] [doi:10.1097/00149831-200308000-00010]
77. Schiele F, Batur MK, Seronde MF, Meneveau N, Sewoke P, Bassignot A, Couetdic G, Caulfield F, Bassand JP. Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study. Heart 2001;85:304-11. [11179272] [doi:10.1136/heart.85.3.304]
78. Limnell V, Pasternack R, Karjalainen J, Virtanen V, Lehtimaki T, Aittoniemi J. Seropositivity for Helicobacter pylori antibodies is associated with lower occurrence of venous bypass graft occlusion. Scand J Infect Dis 2004;36:601-3. [15370672] [doi:10.1080/ 00365540410016753]
79. Rechciński T, Kasprzak JD, Chmiela M, Krzemińska-Pakuła M, Rudnicka W. Patients with unstable angina pectoris present increased humoral response against Helicobacter pylori in comparison with patients with aggravated dyspepsia. Acta Microbiol Pol 2002;51:339-44. [12708822]
80. Rechciński T, Grebowska A, Kurpesa M, Rudnicka W, Krzemińska-Pakula M, Chmiela M. Occurrence of serum class G immunoglobulins interacting with specific antigens of Helicobacter pylori in patients with unstable coronary artery disease and in symptomless individuals. Pol J Microbiol 2005; 54:221-5. [16450838]
81. Grebowska A, Rechcinski T, Bak-Romaniszyn L, Czkwianianc E, Moran A, Druszczyńska M, Kowalewicz-Kulbat M, Owczarek A, Dziuba M, Krzemińska-Pakuła M, Planeta-Malecka I, Rudnicka W, Chmiela M. Potential role of LPS in the outcome of Helicobacter pylori related diseases. Pol J Microbiol 2006; 55:25-30. [16878600]
82. Candore G, Aquino A, Balistreri CR, Bulati M, Di Carlo D, Grimaldi MP, Listì F, Orlando V, Vasto S, Caruso M, Colonna-Romano G, Lio D, Caruso C. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4. Ann N Y Acad Sci 2006;1067:282-7. [16803999] [doi:10.1196/annals.1354.037]
83. Viskum K. Peptic ulcer and pulmonary disease. Scand J Respir Dis 1974;55:284-90. [4458063]
84. Bonnevie O. Causes of death in duodenal and gastric ulcer. Gastroenterology 1977;73:1000-4. [908479]
85. Hole DJ, Quigley EM, Gillis CR, Watkinson G. Peptic ulcer and cancer, Scand J Gastroenterol 1987; 22:17-23. [3563407] [doi:10.3109/ 00365528708991850]
86. Moller H, Toftgaard C. Cancer occurrence in a cohort of patients surgically treated for peptic ulcer, Gut 1991;32:740-4. [1855679] [doi:10.1136/gut.32.7.740]
87. Caygill CP, Knowles RL, Hall R. Increased risk of cancer mortality after vagotomy for peptic ulcer: a preliminary analysis. Eur J Cancer Prev 1991;1:35-7. [1842681] [doi:10.1097 /00008469-199110000-00007]
88. Svanes C, Lie SA, Lie RT, Soreide O, Svanes K. Causes of death in patients with peptic ulcer perforation: a long-term follow-up study. Scand J Gastroenterol 1999;34:18-24. [10048727] [doi:10.1080/ 00365529950172772]
89. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs, JAMA 2004; 292:1955-60. [15507580] [doi:10.1001/jama.292.16.1955]
90. Roussos A, Philippou N, Gourgoulianis KI. Helicobacter pylori infection and respiratory diseases: a review. World J Gastroenterol 2003;9:5-8. [12508341]
91. Lundegardh G, Helmick C, Zack M, Adami HO. Mortality among patients with partial gastrectomy for benign ulcer disease. Dig Dis Sci 1994; 39:340-6. [8313816] [doi:10.1007/BF02090206]
92. Gocyk W, Nikliski T, Olechnowicz H, Duda A, Bielanski W, Konturek P, Konturek SJ. Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer. Med Sci Monit 2000;6:1085-92. [11208460]
93. Philippou N, Koursarakos P, Anastasakou E, Krietsepi V, Mavrea S, Roussos A, Alepopoulou D, Iliopoulos I. Helicobacter pylori seroprevalence in patients with lung cancer. World J Gastroenterol 2004;10:3342-4. [15484314]
94. Rosenstock SJ, Jorgensen T, Andersen LP, Bonnevie O. Association of Helicobacter pylori infection with lifestyle, chronic disease, body indices and age at menarche in Danish adults. Scand J Public Health 2000;28:32-40. [10817312]
95. Roussos A, Philippou N, Krietsepi V, Anastasakou E, Alepopoulou D, Koursarakos P, Iliopoulos I, Gourgoulianis K. H. pylori seroprevalence in patients with chronic obstructive pulmonary disease. Respir Med 2005;99:279-84. [15733502] [doi:10.1016/ j.rmed.2004.08.007]
96. Perri F, Clemente R, Festa V, De Ambrosio CC, Quitadamo M, Fusillo M, Grossi E, Andriulli A. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and Cag A antibodies. Ital J Gastroenterol Hepatol 1999;290-294.
97. Russo F, Jirillo E, Clemente C, Messa C, Chiloiro M, Riezzo G, Amati L, Caradonna L, Di Leo A. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol Immunotoxicol 2001;23:13-24. [11322645] [doi:10.1081/IPH-100102563]
98. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-a in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-4. [8564092]
99. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001;34:50s-59s. [12392035] [doi:10.1183/ 09031936.01.00229701]
100. Pitsiou G, Kyriazis G, Hatzisi O, Argyropoulou P, Mavrofridis E, Patakas D. Tumor necrosis factor-alpha serum levels, weight levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir Med 2002;96:594-8. [12195840] [doi:10.1053/ rmed.2002.1322]
101. Tsang KW, Lam WK, Chan KN, Hu W, Wu A, Kwok E, Zheng L, Wong BC, Lam SK. Helicobacter pylori seroprevalence in asthma. Respir Med 2000;94:756-9. [10955750] [doi:10.1053/rmed.2000.0817]
102. Sanaka M, Kuyama Y, Iwasaki M, Hanada Y, Tsuchiya A, Haida T, Hirama S, Yamaoka S, Yamanaka M. No difference in seroprevalences of Helicobacter pylori infection between patients with pulmonary tuberculosis and those without. J Clin Gastroenterol 1998; 27:331-4. [9855263] [doi:10.1097/00004836-199812000-00010]
103. Tsang KW, Lam SK, Lam WK, Karlberg J, Wong BC, Hu WH, Yew WW, Ip MS. High seroprevalence of Helicobacter pylori in active bronchiectasis. Am J Respir Crit Care Med 1998;158:1047-51. [9769259]
104. Wedi B, Wagner S, Werfel T, Manns MP, Kapp A. Prevalence of Helicobacter pylori associated gastritis in chronic urticaria. Int Arch Allergy Immunol 1998;116:288-94. [9693279] [doi:10.1159/ 000023958]
105. Wedi B, Kapp A. Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol 2002;3:273-82. [12010072] [doi:10.2165/00128071-200203040-00005]
106. Jiménez Saab N, Gómez Vera J, López Tiro JJ, Cruz Parada M, Ahumada Trujillo J, Cisneros Sotelo L, Sampedro Carrillo E, Morales Villarruel P, Reyes Salinas A. Association between chronic urticaria and Helicobacter pylori. Rev Alerg Mex 2007; 54:111-5. [18297850]
107. Sianturi GN, Soebaryo RW, Zubier F, Syam AF. Helicobacter pylori infection: prevalence in chronic urticaria patients and incidence of autoimmune urticaria (study in Dr. Cipto Mangunkusumo Hospital, Jakarta). Acta Med Indones 2007;39:157-62. [18046060]
108. Clements PJ, Becvar R, Drosos AA, Ghattas L, Gabrielli A. Assessment of gastrointestinal involvement. Clin Exp Rheumatol 2003; 21:S15-8. [12889216]
109. Reinauer S, Goerz G, Ruzicka T, Susanto F, Humfeld S, Reinauer H. Helicobacter pylori in patients with systemic sclerosis: detection with the 13C-urea breath test and eradication. Acta Derm Venereol 1994;74:361-3. [7817672]
110. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991;100:1495-501. [2019355]
111. Aragona P, Magazzu G, Macchia G, Bartolone S, Di Pasquale G, Vitali C, Ferreri G. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjogren's syndrome. J Rheumatol 1999;26:1306-11. [10381048]
112. Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, Tamaki T, Tamaki K. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol. 1998;25:650-3. [9558164]
113. McNamara D, O'Morain C. Gastrooesophageal reflux disease and Helicobacter pylori: an intricate relation. Gut 1999; 45:I13-7. [10457030]
114. Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Färkkilä M. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000; 61:6-13. [10671769] [doi:10.1159/000007730]
115. Wu JC, Sung JJ, Chan FK, Ching JY, Ng AC, Go MY, Wong SK, Ng EK, Chung SC. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14:427-32. [10759622] [doi:10.1046/j.1365-2036.2000.00714.x]
116. Yamaguchi K, Iwakiri R, Hara M, Kikkawa A, Fujise T, Ootani H, Shimoda R, Tsunada S, Sakata S, Ushiyama O, Koarada S, Tada Y, Nagasawa K, Fujimoto K. Reflux Esophagitis and Helicobacter pylori Infection in Patients with Scleroderma. Intern Med 2008;47: 1555-9. [18797112] [doi:10.2169/internalmedicine.47.1128]